Palladia 15 mg 4 x 5 tabletten

Nr.
1204078
Brand:
Zoetis
Batch:
CH6943
Expiry date:
30-Jun-2021
Only 2 left
For the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement
More info

Palladia 15 mg 4 x 5 tabletten

Target species
Dog

Indications
Palladia tablets are indicated for the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs

Contra-indications
Do not use in dogs used for breeding, or for pregnant or lactating bitches

Route of administration and dosage
Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight, orally every other day (see Table 1). Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized, if needed, to manage adverse reactions (see Table 2 as well as Warnings and Precautions). Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks, thereafter. PALLADIA may be administered with or without food. Do not split tablets.

More Information
Nr. 1204078
Registration number REG NL 102792
Brand Zoetis
Chilled No
Active Ingredient Toceranib
Target species Dog
Legal status of supply UDA
Route of administration Oral
Withdrawal period 0 days
Batch CH6943
Expiry date Jun 30, 2021
Units per outer box 0
© 2020 Grovet B.V. All rights reserved.